Wordt geladen...
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
Neuroblastoma (NB) is a pediatric cancer of the sympathetic nervous system which accounts for 8% of childhood cancers. Most NBs express high levels of the disialoganglioside GD2. Several antibodies have been developed to target GD2 on NB, including the human/mouse chimeric antibody ch14.18, known as...
Bewaard in:
| Gepubliceerd in: | Biologics |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6306059/ https://ncbi.nlm.nih.gov/pubmed/30613134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S114530 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|